Ecopipam as a Treatment for Tourette Syndrome: Phase 3 Clinical Trial Results by Madaline Spencer| Published on: May 13, 2026

Ecopipam as a Treatment for Tourette Syndrome: Phase 3 Clinical Trial Results by Madaline Spencer| Published on: May 13, 2026 Kinga Tomczak, MD, PhD, Program Director of the Tic Disorders and Tourette Syndrome Program at Boston Children’s Hospital and Assistant Professor of Neurology at Harvard Medical School, discusses phase 3 clinical trial results of ecopipam as a treatment for Tourette syndrome. https://checkrare.com/ecopipam-as-a-treatment-for-tourette-syndrome-phase-3-clinical-trial-results/